Yahoo
ASX - Delayed Quote AUD

nib holdings limited (NHF.AX)

6.61 +0.08 (+1.23%)
At close: October 30 at 4:10:10 PM GMT+11
Chart Range Bar
Loading chart for NHF.AX
  • Previous Close 6.53
  • Open 6.60
  • Bid 6.55 x --
  • Ask 6.68 x --
  • Day's Range 6.54 - 6.70
  • 52 Week Range 5.79 - 7.73
  • Volume 1,028,873
  • Avg. Volume 999,190
  • Market Cap (intraday) 3.243B
  • Beta (5Y Monthly) 0.10
  • PE Ratio (TTM) 17.39
  • EPS (TTM) 0.38
  • Earnings Date Aug 24, 2026
  • Forward Dividend & Yield 0.29 (4.39%)
  • Ex-Dividend Date Sep 3, 2026
  • 1y Target Est 7.37

nib holdings limited, together with its subsidiaries, engages in the underwriting and distribution of private health, life, and living insurance to residents, international students, and visitors in Australia and New Zealand. The company operates in six segments: Australian Residents Health Insurance, International (Inbound) Health Insurance, New Zealand Insurance, nib Travel, nib Thrive, and nib Health Services. It also offers travel and disability insurance products. In addition, the company provides health and wellbeing, telehealth, and treatment delivery services, as well as health management programs. Further, it provides digital marketplace platform under the national disability insurance scheme (NDIS). The company was founded in 1952 and is based in Newcastle, Australia.

www.nib.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

NHF.AX
1.47%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

NHF.AX
7.68%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

NHF.AX
4.46%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

NHF.AX
22.11%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

6.60
7.37 Average
6.61 Current
8.25 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.92%

  • Return on Assets (ttm)

    7.82%

  • Return on Equity (ttm)

    16.37%

  • Revenue (ttm)

    3.81B

  • Net Income Avi to Common (ttm)

    185.3M

  • Diluted EPS (ttm)

    0.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.33B

  • Total Debt/Equity (mrq)

    19.90%

  • Levered Free Cash Flow (ttm)

    194.08M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: